ECTS
120 crédits
Niveau d'études visé
BAC +5 (niveau 7)
Durée
2 ans
Langue des enseignements
Anglais
Présentation
The EMJMD NANOMED “nanomedicine for drug delivery” (information and applications on our website: http://www.master-nanomed.eu/), directed by Prof. Karine Andrieux and Dr. Caroline Roques, is an English taught curriculum. The first semester is a joint programme with the Master 2 degree « Pharmaceutical Technology » .
This university program is in the Graduate Schools of Cardiovascular Sciences and Drug Development at Université Paris Cité. It connects master's and doctoral courses with advanced research labs.
- The Graduate School of Cardiovascular Sciences provides diverse training in cardiovascular research. Read more >
- The Graduate School of Drug Development is focused on creating new drugs, covering all stages from design to clinical use. Read more >
Objectifs
The EMJMD NANOMED aims at educating young scientists towards general principles of drug development. More specifically, this curriculum focuses on drug delivery systems and pharmaceutical technology using both classical dosage forms and innovative delivery systems.
Compétences visées
Enrolled students are beneficiating from both theoretical and practical courses. Various aspects of pharmaceutical technology related to vectorisation, diagnostic, delivery of innovative drugs (proteins and nucleic acids) but also distinctive features of cosmetic products are part of the curriculum.
Programme
Students must validate theoretical and practical courses during semesters 1 and 3 (30 ECTS), theoretical and practical courses and 3-month traineeship during semester 2 (30 ECTS) and a traineeship of 6 months (30 ECTS) during semester 4.
First semester: From mid-September to end of January: in Paris University or Patras
Second semester form February to end of March, traineeship from April to June, summer school and workshop in July
Third semester from September to end of December
Semester 4: 6-month traineeship from January to June and final workshop in July
Sélectionnez un programme
Master 1 Sciences du médicament et des produits de santé - Parcours : Nanomedicine for drug delivery
Preformulation and formulation strategy
3 créditsClassical and controlled release dosage forms
6 créditsPractical applications of formulations
6 créditsPharmaceutical technologies
6 créditsInnovative forms and introduction to nanomedicine
6 créditsAu choix
3 créditsAu choix : 1 parmi 2
Basic chemistry
3 créditsBasic biology
3 crédits
Basic nanomedicine
9 créditsBiomolecules
3 créditsTraineeship
15 créditsSummer school and workshop
3 crédits
Master 2 Sciences du médicament et des produits de santé - Parcours : Nanomedicine for drug delivery
Au choix : 1 parmi 2
Itinéraire Pavia pathway : Production and applications of nanoparticles
30 créditsNanotechnology and biologic/biotec drugs
7 créditsSite/time specific application
5 créditsIndustrialization
4 créditsDrug targeting and vaccination
7 créditsSpecific nanomedicine applications
5 créditsPersonal Development
2 crédits
Itinéraire Angers pathway : Strategy of nanomedicine development for clinical application
30 créditsCMC Regulatory and QbD Approach
5 créditsInnovation and Applications
4 créditsDrug product design
5 créditsCharacterization strategy
5 créditsNon-Clinical strategy
5 créditsPersonal development & Occupational integration
1 créditsInnovation Project
5 crédits
Stage pratique
30 crédits
Stages et projets tutorés
The 3-month-traineeship will be evaluated thanks a poster presentation during the workshop of year 1. A report and a defence of the 6-month traineeship will be presented in the workshop of the second year.
Contrôle des connaissances
Students will be evaluated according to the following European grading system:
|
Average grade |
A |
B |
C |
D |
E |
|
Distinction |
Excellent |
Very Good |
Good |
Quite Good |
Pass |
To pass a study unit/course, students must obtain at least an E mark. At the end of each semester, students will have to validate the 30 ECTS according to the modalities defined by the hosting member of the Consortium. The corrected tests will be open to consultation after addressing a formal request to the professor in charge; all kinds of exams (written, oral presentation, individual report etc.) will be stored for one year after the end of the intake at the member of the Consortium in which the exam took place.
In case of failure, a single re-sit examination will be organized; should the student fail again, he/she will have to quit the NANOMED EMJMD.
Following this traineeship, the students will write-up a report that will constitute his/her Master Thesis and that will be submitted to appropriate reviewers. This dissertation will then be presented viva voce during the workshop following the Summer School in front of an International jury.
For more details please see (en savoir+)
Aménagements particuliers
All information about the 4 European universities partners and our programme are available on the website.
All applications must be done directly on the website : http://www.master-nanomed.eu/.
For people with disabilities, please see here.
Admission
Public cible
Tous les étudiants issus des filières scientifique ou santé
Conditions d'admission
A bachelor in Pharmaceutical technology, pharmacist, chemist, biologist(biotechnology) or equivalent is mandatory.
Pré-requis
The selection criteria are academic level, English proficiency, previous experience during internship (2 months min) in pharmaceutical technology and a clear professional project. Other mandatory documents are presented in the website: http://www.master-nanomed.eu/.
Modalités de candidature
Application form and documents (1st step) directly on the website : http://www.master-nanomed.eu/ and interview in english (2nd step)
.
Droits de scolarité
Et après ?
95 à 100 %
Taux de réussite (Le taux de réussite varie de 95 à 100 % selon les promotions)
Poursuites d'études
This programme is opening up career opportunities in drug delivery and cosmetics but also allowing students to pursue their research training by doing a PhD.
Débouchés professionnels
This programme is opening up career opportunities in drug delivery and cosmetics but also allowing students to pursue their research training by doing a PhD.
Référentiel
Référentiel RNCP
38985
International
Mobilité internationale
This programme is a joint European programme : EMJMD Nanomed (information and applications on our website: http://www.master-nanomed.eu/). European and Non-European applicants can beneficiate of grants by applying to this Nanomed master in 2 years.
Poursuites d'études à l'étranger
PhD opportunities.
Contacts
Karine Andrieux
Responsable du diplômeCaroline Roques
Co-responsable du diplôme- Contact administratif
- Contact administratif
Dernière mise à jour le 7 octobre 2024
A lire aussi
Du vendredi 15 au dimanche 17 novembre 2024, l’université Paris Cité sera présente au Salon européen de l’éducation dédié à l’orientation des jeunes publics.
Dans le cadre de sa stratégie d’établissement, l’université Paris Cité coordonne plusieurs projets visant à accompagner la transformation interne de l’établissement et ses interactions avec le territoire. Parmi ces projets figure FIRE-UP, (renForcer l’Interdisciplinarité et la Recherche d’Excellence pour la société à Université Paris Cité), un programme de transformation axé sur l’innovation interdisciplinaire et l’impact sociétal, dont le site web a été lancé le 31 octobre 2024.
L’Éducation nationale recrute et forme 25 000 professeurs chaque année. Vous avez jusqu’au jeudi 21 novembre 2024 pour vous inscrire aux concours de recrutement d’enseignants de la session 2025.
Avec ses 3050 doctorantes, doctorants et une politique d’attractivité ambitieuse, UPCité s’efforce de rendre ses docteurs visibles et reconnus au-delà du monde académique. À la suite de la remise du rapport sur la valorisation du doctorat dans les entreprises, nous avons rencontré Raphaël Porcher, directeur du collège des écoles doctorales de l’université Paris Cité. Il revient pour nous sur les enjeux et les actions mises en place par l’université pour faciliter l’insertion des doctorantes et doctorants dans le secteur privé, tout en renforçant l’excellence de leur formation.
